Name | LHC-165 |
---|
Description | LHC-165 is a TLR7 agonist. Has potential to treat solid tumors[1][2]. |
---|---|
Related Catalog | |
Target |
TLR7 |
References |
[2]. LHC165. |
Molecular Formula | C29H32F2N3O7P |
---|---|
Molecular Weight | 603.55 |